FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants

46Report
FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants

The FDA said it was withdrawing its emergency use authorization of Evusheld, a preventive COVID drug, because of its lack of effectiveness against omicron subvariants.

Similar news

Share
Report

Report this article here.